Sendero Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$673K Sell
732
-53
-7% -$53.7K 0.07% 139
2025
Q4
$843K Buy
+785
New +$751K 0.09% 121

Other funds holding LLY

Sendero Wealth Management's LLY Position: Q1 2026 in Review

Sendero Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $53.7K and leaving 732 shares worth $673K. The position accounts for 0.07% of the portfolio, ranked #139.

Sendero Wealth Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $843K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sendero Wealth Management held 732 shares of Eli Lilly worth $673K as of Q1 2026.
  • Sendero Wealth Management sold 53 Eli Lilly shares in Q1 2026, an estimated $53.7K.
  • Eli Lilly made up 0.07% of Sendero Wealth Management's portfolio in Q1 2026, its #139 holding.
  • Sendero Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Sendero Wealth Management's Eli Lilly position peaked at $843K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sendero Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.